| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2014-06-27 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 3,403,562 | 2.7% | EDGAR |
| SC 13G/A | 2014-02-14 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2014-02-14 | Flynn James E | ARRAY BIOPHARMA INC | 23,235,406 | 10.0% | EDGAR |
| SC 13G | 2014-02-10 | PRICE T ROWE ASSOCIATES INC /MD/ | ARRAY BIOPHARMA INC | 9,014,300 | 7.2% | EDGAR |
| SC 13G/A | 2014-01-28 | BlackRock Inc. | ARRAY BIOPHARMA INC | 11,001,611 | 8.9% | EDGAR |
| SC 13G | 2014-01-10 | FMR LLC | ARRAY BIOPHARMA INC | 14,367,220 | 11.5% | EDGAR |
| SC 13G/A | 2013-03-11 | BlackRock Inc. | ARRAY BIOPHARMA INC | 11,773,273 | 10.1% | EDGAR |
| SC 13G/A | 2013-02-14 | FMR LLC | ARRAY BIOPHARMA INC | 2,403,770 | 2.1% | EDGAR |
| SC 13G/A | 2013-02-14 | Flynn James E | ARRAY BIOPHARMA INC | 23,244,700 | 10.0% | EDGAR |
| SC 13G/A | 2013-02-06 | BlackRock Inc. | ARRAY BIOPHARMA INC | 7,021,784 | 6.0% | EDGAR |
| SC 13G/A | 2012-11-19 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 790,501 | 8.8% | EDGAR |
| SC 13D/A | 2012-02-17 | KOPP INVESTMENT ADVISORS LLC | ARRAY BIOPHARMA INC | 2,618,716 | 4.3% | EDGAR |
| SC 13G/A | 2012-02-14 | FMR LLC | ARRAY BIOPHARMA INC | 3,938,770 | 6.7% | EDGAR |
| SC 13G/A | 2012-02-14 | Flynn James E | ARRAY BIOPHARMA INC | 13,190,925 | 10.0% | EDGAR |
| SC 13G/A | 2012-02-14 | Capital Research Global Investors | ARRAY BIOPHARMA INC | - | 0.0% | EDGAR |
| SC 13G/A | 2012-02-13 | BlackRock Inc. | ARRAY BIOPHARMA INC | 4,230,466 | 7.2% | EDGAR |
| SC 13G/A | 2012-02-10 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 1,715,269 | 2.8% | EDGAR |
| SC 13G/A | 2011-11-04 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 1,674,216 | 2.9% | EDGAR |
| SC 13G | 2011-08-18 | BIOTECHNOLOGY VALUE FUND L P | ARRAY BIOPHARMA INC | 718,023 | 1.3% | EDGAR |
| SC 13G/A | 2011-08-10 | COLUMBIA WANGER ASSET MANAGEMENT LLC | ARRAY BIOPHARMA INC | 10 | - | EDGAR |